Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma
Ting Li, Pei-Shan Hu, Zhixiang Zuo, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 634

Showing 1-25 of 634 citing articles:

Functions of N6-methyladenosine and its role in cancer
Liuer He, Huiyu Li, Anqi Wu, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 1092
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
Huilin Huang, Hengyou Weng, Jianjun Chen
Cancer Cell (2020) Vol. 37, Iss. 3, pp. 270-288
Open Access | Times Cited: 935
The potential role of RNA N6-methyladenosine in Cancer progression
Tianyi Wang, Shan Kong, Mei Tao, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 792
The role of m6A RNA methylation in cancer metabolism
Yuanyuan An, Hua Duan
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 476
METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST
Xiao Yang, Sen Zhang, Changyu He, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 441
Roles of METTL3 in cancer: mechanisms and therapeutic targeting
Chengwu Zeng, Wanxu Huang, Yangqiu Li, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 424
Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells
Jia Xiong, Jia He, Jun Zhu, et al.
Molecular Cell (2022) Vol. 82, Iss. 9, pp. 1660-1677.e10
Open Access | Times Cited: 403
RETRACTED ARTICLE: m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
Dan Jin, Jiwei Guo, Yan Wu, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 402
KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3
Tian Lan, Hui Li, Zhang Delin, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 362
The role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities
Paz Nombela, Borja Miguel‐López, Sandra Blanco
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 355
m6A-dependent glycolysis enhances colorectal cancer progression
Chaoqin Shen, Baoqin Xuan, Tingting Yan, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 322
Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway
Wen Peng, Jie Li, Ranran Chen, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 309
HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation
Qing Li, Yong Ni, Liren Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 282
m6A modification: recent advances, anticancer targeted drug discovery and beyond
Lijuan Deng, Wei-Qing Deng, Shu-Ran Fan, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 261
m6A-binding proteins: the emerging crucial performers in epigenetics
Yanchun Zhao, Yuanfei Shi, Huafei Shen, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 244
Mechanism of RNA modification N6-methyladenosine in human cancer
Zijian Zhou, Jiancheng Lv, Hao Yu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 224
N6-methyladenosine METTL3 promotes cervical cancer tumorigenesis and Warburg effect through YTHDF1/HK2 modification
Qianqing Wang, Xiangcui Guo, Li Li, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 10
Open Access | Times Cited: 216
RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer
Yang Zhou, Tingfeng Wang, Dejun Wu, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 208
The m6A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function
Lifang Ma, Tianxiang Chen, Xiao Zhang, et al.
Redox Biology (2020) Vol. 38, pp. 101801-101801
Open Access | Times Cited: 199
RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent
Xin Wang, Linli Tian, Yushan Li, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 199
Epigenetic Regulation of m6A Modifications in Human Cancer
Wei Zhao, Xiaoqian Qi, Lina Liu, et al.
Molecular Therapy — Nucleic Acids (2019) Vol. 19, pp. 405-412
Open Access | Times Cited: 197
Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis
Jin‐Fei Lin, Peishan Hu, Yiyu Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 189
The Emerging Roles of RNA m6A Methylation and Demethylation as Critical Regulators of Tumorigenesis, Drug Sensitivity, and Resistance
Qing Lan, Pei Y. Liu, Jessica L. Bell, et al.
Cancer Research (2021) Vol. 81, Iss. 13, pp. 3431-3440
Open Access | Times Cited: 187
Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms
Jia-nan Wang, Fang Wang, Jing Ke, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 640
Closed Access | Times Cited: 184
Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer
Huifang Chen, Jiameng Yao, Rujuan Bao, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 182
Page 1 - Next Page

Scroll to top